• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 25 X 40, FIRM; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 25 X 40, FIRM; MESH, SURGICAL Back to Search Results
Catalog Number 2540002
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Bacterial Infection (1735); Necrosis (1971)
Event Date 01/15/2015
Event Type  Injury  
Manufacturer Narrative
This legal event is being reported as serious injury due to the reported complications with surgical intervention.The lot associated with this event was not reported and remains unknown; therefore a review of the device history records could not be performed.No strattice devices were returned for evaluation.Based on the limited information reported, a relationship between the event and strattice cannot be confirmed.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Event Description
It was reported through a legal event that a (b)(6) year old female patient had ventral incisional hernia repair surgery on or about (b)(6) 2014.During the hernia repair surgery, the surgeon implanted a strattice mesh.After surgery, the patient returned to the hospital on or about (b)(6) 2015 and was diagnosed with ischemic necrosis of the central portion of her midline incision.On or about (b)(6) 2015, the patient underwent the excision and debridement of an open abdominal wound.On or about (b)(6) 2015, the patient underwent abdominal wall debridement with wound vac placement.The strattice mesh was noted to have separated from the healing tissue and was incised.The patient presented several more times throughout 2015 for treatment of abdominal wall pain, wound infection, and dehiscence, and underwent additional excisional debridement of abdominal wound.
 
Manufacturer Narrative
Internal investigation into strattice lot sp100130 included a review of the reported information, review of the device history records, and a review of the complaint history records.The investigation resulted in no remarkable findings, including no other complaints reported against the lot and no deviations or related non-conformances revealed during processing.The lot was terminally sterilized within the process parameters and met all qc release criteria.As of 9/23/2022, of the (b)(4) devices released to finished goods for lot sp100130, (b)(4) have been distributed with (b)(4) reported as implanted.Based on our internal investigation with no remarkable findings, and without relevant patient factors, a relationship between the strattice and this event could not be determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
 
Event Description
This is follow up#1 to report on 9/14/2022, pmqa received notification from legal that the lot associated with this event was found through discovery and is sp100130-005.No other information was reported.As reported in the initial: it was reported through a legal event that a 48 year old female patient had ventral incisional hernia repair surgery on or about (b)(6) 2014.During the hernia repair surgery, the surgeon implanted a strattice mesh.After surgery, the patient returned to the hospital on or about (b)(6) 2015 and was diagnosed with ischemic necrosis of the central portion of her midline incision.On or about (b)(6) 2015, the patient underwent the excision and debridement of an open abdominal wound.On or about (b)(6) 2015, the patient underwent abdominal wall debridement with wound vac placement.The strattice mesh was noted to have separated from the healing tissue and was incised.The patient presented several more times throughout 2015 for treatment of abdominal wall pain, wound infection, and dehiscence, and underwent additional excisional debridement of abdominal wound.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 25 X 40, FIRM
Type of Device
MESH, SURGICAL
Manufacturer Contact
christopher belle
1 millennium way
branchburg, NJ 08876
9089471470
MDR Report Key13845499
MDR Text Key287596039
Report Number1000306051-2022-00042
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K070560
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number2540002
Device Lot NumberSP100130
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received09/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NO INFORMATION REPORTED.
Patient Outcome(s) Required Intervention;
Patient Age48 YR
Patient SexFemale
-
-